Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2002
04/10/2002EP0734387B1 Hiv protease inhibitors
04/10/2002EP0732329B1 Chroman derivative
04/10/2002EP0712402B1 Hydroisoquinoline derivatives
04/10/2002CN1344322A BASBO55 polynucleotide and polypeptide from neisseria meningitidis uses thereof
04/10/2002CN1344318A Protein for blocking platelet adhesion
04/10/2002CN1344317A 多肽 Polypeptide
04/10/2002CN1344270A Functionalized heterocycles as chemokine receptor modulators
04/10/2002CN1344269A Pharmaceutical compsn. based on polyaromatic compounds
04/10/2002CN1344268A Use of imidazo [1,5-a]pyrido[3,2-e]-pyrazinones as medicaments
04/10/2002CN1344267A Substituted 1-(pieridin-4-Yl)-3-(aryl) isothioureas their prepn. and therapeutic application
04/10/2002CN1344266A Novel compounds
04/10/2002CN1344265A Piperidine, tetrahydropyridine and piperazine derivatives, their prepn. and use
04/10/2002CN1344264A Tetrahydropyran derivatives and their use as therapeutic agents
04/10/2002CN1344257A Fused pydiopyridazine inhibitors of cGMP phosphodiesterase
04/10/2002CN1344256A (Hetero) aryl-bicyclic heteroaryl derivatives, their prepn. and their use as protease inhibitors
04/10/2002CN1344250A 间苯二酚衍生物 Resorcinol derivatives
04/10/2002CN1344249A 酰胺衍生物 Amide derivatives
04/10/2002CN1344247A Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4
04/10/2002CN1344245A Branched chain amino acid-dependent aminotransferase inhibitors and their use in treatment of diabetic retinopathy
04/10/2002CN1344241A Method of industrial-scale purification of lactic acid
04/10/2002CN1344168A Ophthalmic compsns.
04/10/2002CN1344166A Use of enterobacterium protein ompA associated with antigen for generating antiviral, antiparasitic or antitumoral cytotoxic response
04/10/2002CN1344162A Medical compsns.
04/10/2002CN1344161A Use of pyridazino [4,5-i(b)]indole-1-acetamide derivatives for preparing medicines for treating disease related to dysfunction of peripheral benzodiazepin receptors
04/10/2002CN1344160A Heterocyclic aromatic compounds useful as growth hormone secretagogues
04/10/2002CN1344159A Combinations for treatment of diseases involving angiogenesis
04/10/2002CN1344158A Gardos channel antagonists
04/10/2002CN1344157A Use of certain offinity NMDA antagonists as antidepressants
04/10/2002CN1344154A Absorbent article compsn. and method of use for sequestering skin irritants
04/10/2002CN1344153A Facial tissue compsn. and method of use for sequestration of nasal secretion skin irritants
04/10/2002CN1344152A Resorcinol compsn.
04/10/2002CN1344135A Organ arrest, protection and preservation
04/10/2002CN1343729A Liquorice polyose
04/10/2002CN1343728A Natural plant polyose
04/10/2002CN1343727A Polymannuronic acid sulfate
04/10/2002CN1343663A Amlodipine-series salts and preparing process and application thereof
04/10/2002CN1343515A Areca for giving up smoking and its preparing process
04/10/2002CN1343514A Chinese medicine for treating fatty liver
04/10/2002CN1343493A Application of N-gluco-N-bithiocarboxylic acid-L-amino acid sodium in repelling Pt
04/10/2002CN1343492A Taxol-series compound anticancer medicines
04/10/2002CN1343491A Method for localized anesthesia and analgesia
04/10/2002CN1343490A Sophoridine and its application in analgesic
04/10/2002CN1343489A Percutaneous absorption type anticancer medicine to suppress hyperplasia and untoward differentiation of cells
04/10/2002CN1082543C Polycyclic antiparasitic agents, process and strain for their prepn. and use
04/10/2002CN1082511C Phophorus contg. cythesine derivs.
04/10/2002CN1082509C Camptothecin-skeleton compounds isolated from mappia foetida and use thereof as syntones for medicaments as well as therapeutical agents
04/10/2002CN1082508C antivirally active heterocyclic azahexane derivatives
04/10/2002CN1082378C Externally-used arthralgia treating medicine and its prepn. method
04/10/2002CN1082373C Medicines and drinking products for prevention and treatment gastrointestinal diseases
04/10/2002CN1082372C Liquid medicine for treating bromidrosis, and its prepn. method
04/10/2002CN1082371C NK-1 receptor antagonist and 5HT3 receptor antagonists for treating emesis
04/10/2002CN1082370C Pharmaceutical compsn. contg. 4-oxo-butynic acid
04/10/2002CN1082369C Formulations contg. carotenoids and procarotenoids combined with polyphenols
04/10/2002CN1082368C HCG liquid formulations
04/10/2002CN1082367C Topical ophthalmic formulations contg. doxepin derivatives for treating allergic eye diseases
04/10/2002CN1082363C Methods of using cyclicpolyanionic polyol derivatives for regulating skin wrinkles
04/10/2002CN1082337C Feeds compsn and nutritious agent contg. triterpenic saponin extract
04/09/2002USRE37650 Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
04/09/2002US6369289 Method and manufacture of a wound dressing for covering an open wound
04/09/2002US6369273 Chemical compounds and their use to elevate pyruvate dehydrogenase activity
04/09/2002US6369260 Process for the preparation of a pharmacologically active chemical combination
04/09/2002US6369252 Structured lipids
04/09/2002US6369246 Synthesis and pharmaceuticals of novel 9-substituted-1, 5-dichloroanthracene analogs
04/09/2002US6369236 Imidazole derivatives with biphenylsulfonyl substitution method for preparing them and their use as a drug or diagnostic agent
04/09/2002US6369235 Inhibitors of hiv reverse transcription for treatment of aids
04/09/2002US6369234 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
04/09/2002US6369232 Antidiabetic agents
04/09/2002US6369229 Pyridylalanine derivatives
04/09/2002US6369228 Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain
04/09/2002US6369227 Thrombin or factor Xa inhibitors
04/09/2002US6369226 Substituted benzamide inhibitors of rhinovirus 3C protease
04/09/2002US6369224 Spiroazabicyclic heterocyclic amine borane complexes; psychological, nervous system and brain disorders; anxiolytic agents, antidepressants, analgesics; alzheimer*s and parkinson*s disease; smoking cessationa
04/09/2002US6369222 mGluR antagonists and a method for their synthesis
04/09/2002US6369221 Anticonvulsants, antiischemic agents; brain and nervous system disorder treatment
04/09/2002US6369220 Oxidizing an aryl-3-hydroxypropylsulfide; oxidizing 3-hydroxy group into aryl-3-propanalsulfoxide; cyclization
04/09/2002US6369219 Preparation of clavulanate salts
04/09/2002US6369216 Enhances immune response without stimulating production of biochemical mediators that cause inflammatory side effects
04/09/2002US6369208 Influenza endonuclease apatamer that inhibits influenza endonuclease and is resistant to cleavage by said enzyme
04/09/2002US6369165 Method for the production of polymers from n-vinyl compounds
04/09/2002US6369115 Stabilized powder formulations
04/09/2002US6369114 Administration of an α2-adrenergic receptor agonist to enhance cardiopulmonary resuscitation
04/09/2002US6369113 Antidepressants, parkinson's disease
04/09/2002US6369109 Betulinic acid and derivatives thereof useful for the treatment of neuroectodermal tumor
04/09/2002US6369108 Method for treating COPD
04/09/2002US6369107 Combined use of diclofenac and tribenoside to treat osteoarthritis
04/09/2002US6369106 Treatment of ischemic brain injuries with brain targeted anti oxidant compounds
04/09/2002US6369105 Microbicides
04/09/2002US6369103 Hmg coa reductase inhibitor such as pravastatin to a patient which has one or more risk factors for a coronary and/or cerebrovascular event such as hypercholesterolemia
04/09/2002US6369102 Glaucoma
04/09/2002US6369101 Therapeutic method to treat herpes virus infection
04/09/2002US6369100 Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids
04/09/2002US6369099 Method of locking 1 α-OH of vitamin D compounds in axial orientation
04/09/2002US6369098 Peroxisome proliferator-activated receptor-.gamma. (ppar.gamma.) and/or ppar.alpha treatment of endocrine, skin, cardiovascular, immunological, neurological, neuropsychiatric, neoplastic and chronic viral diseases of various organs
04/09/2002US6369097 Treatment and prevention of hepatic disorders
04/09/2002US6369096 Benzyloxy prodigiosine compounds
04/09/2002US6369095 Indole-3-carbinol (13C) derivatives and methods
04/09/2002US6369094 3-(n-methyl-2(r)-pyrrolidinylmethyl)-5-(2-phenylsulphonylethyl )-1h-indole, analgesic for migrane
04/09/2002US6369092 Method for treating neoplasia by exposure to substituted benzimidazole derivatives
04/09/2002US6369091 Benzimidazole analogs as down-regulators of IgE
04/09/2002US6369089 Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2α antagonists